Sanara MedTech CEO has 3,661 shares withheld for taxes

Sanara MedTech’s CEO had shares withheld for taxes upon restricted stock vesting, with no market sale and direct holdings now at 105,885 shares.

Available on EDGAR 09/16/2026 - 04:02 PM EDT Accepted by SEC EDGAR 09/16/2026 - 04:02 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Sanara MedTech Inc. (SMTI) reported that Chief Executive Officer and director Yon Seth D had 3,661 shares of common stock withheld on September 15, 2026 to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock. The shares were withheld by the issuer at a value of $35.11 per share, with 105,885 shares of common stock held directly by the reporting person after this transaction. No shares were issued or sold into the market, and no Rule 10b5-1 trading plan is reported.

Insider Trade Summary

Tax Withholding: 3,661 shares

Tax Withholding 1 txn

Insider Yon Seth D

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	3,661	$35.11	$129K

Holdings After Transaction: Common Stock — 105,885 shares (Direct)

Holdings Before and After: Common Stock, 109,546 to 105,885 shares (Direct)

Footnotes (1)

1. F1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

Key Figures

Shares withheld for tax withholding obligations: 3,661 shares Per-share value for withheld shares: $35.11 per share Restricted stock vested: 9,521 shares +1 more

4 metrics

Shares withheld for tax withholding obligations 3,661 shares Common stock withheld on September 15, 2026

Per-share value for withheld shares $35.11 per share Value reflects price on vesting date reported on Nasdaq Capital Market

Restricted stock vested 9,521 shares Annual vesting of previously granted restricted stock

Shares held after transaction 105,885 shares Direct common stock holdings by CEO following withholding

Key Terms

restricted stock, tax withholding obligations, Nasdaq Capital Market

3 terms

restricted stock financial

"in connection with the annual vesting of 9,521 shares of restricted stock"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

tax withholding obligations financial

"withheld by the Issuer to satisfy tax withholding obligations in connection"

Nasdaq Capital Market market

"price per share on the date on which the shares vested as reported on the Nasdaq Capital Market"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did SMTI’s CEO report in this Form 4 transaction?

The CEO reported that 3,661 SMTI shares were withheld on September 15, 2026 to satisfy tax withholding obligations tied to the vesting of 9,521 restricted shares. The filing states no shares were issued or sold in this transaction.

Was there an open-market sale of SMTI stock by the CEO?

No. The filing states the 3,661 shares were withheld by the issuer to satisfy tax withholding obligations, and that no shares were issued or sold in this transaction.

How many SMTI shares does the CEO hold after this tax-withholding event?

After the tax-withholding event, the CEO directly holds 105,885 shares of Sanara MedTech Inc. common stock, according to the reported post-transaction holdings figure.

What price per share was used for the withheld SMTI shares?

The withheld shares were valued at $35.11 per share. The filing notes this per-share value reflects the price on the vesting date as reported on the Nasdaq Capital Market.

How many restricted SMTI shares vested for the CEO?

The transaction relates to the annual vesting of 9,521 shares of restricted stock previously granted to the CEO. A portion of these vested shares was withheld to cover tax obligations.

Was a Rule 10b5-1 trading plan involved in this SMTI Form 4?

No Rule 10b5-1 plan is reported. The document-level checkbox for Rule 10b5-1 is not marked, and the footnote describes the event solely as shares withheld for tax withholding obligations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yon Seth D

(Last) (First) (Middle)

1200 SUMMIT AVE

SUITE 414

(Street)

FORT WORTH TEXAS 76102

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sanara MedTech Inc. [ SMTI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/15/2026		F		3,661(1)	D	$35.11(1)	105,885	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock of Sanara MedTech Inc. (the "Issuer") withheld by the Issuer to satisfy tax withholding obligations in connection with the annual vesting of 9,521 shares of restricted stock previously granted to the reporting person. No shares were issued or sold in this transaction. The per-share value assigned to the shares withheld reflects the price per share on the date on which the shares vested as reported on the Nasdaq Capital Market.

	/s/ Seth D. Yon	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)